1. Home
  2. CSBR vs ICG Comparison

CSBR vs ICG Comparison

Compare CSBR & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$7.57

Market Cap

98.5M

Sector

Health Care

ML Signal

HOLD

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$2.00

Market Cap

97.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
ICG
Founded
1985
2017
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
97.1M
IPO Year
1986
2023

Fundamental Metrics

Financial Performance
Metric
CSBR
ICG
Price
$7.57
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$7.50
AVG Volume (30 Days)
5.3K
76.8K
Earning Date
03-10-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.43
EPS
0.17
0.21
Revenue
$58,424,000.00
$36,367,850.00
Revenue This Year
$4.84
N/A
Revenue Next Year
$11.51
$75.98
P/E Ratio
$44.07
$9.38
Revenue Growth
9.06
6.53
52 Week Low
$5.59
$0.93
52 Week High
$11.99
$4.32

Technical Indicators

Market Signals
Indicator
CSBR
ICG
Relative Strength Index (RSI) 61.37 54.66
Support Level $6.62 $1.80
Resistance Level $7.45 $2.28
Average True Range (ATR) 0.31 0.13
MACD 0.05 -0.01
Stochastic Oscillator 88.39 44.57

Price Performance

Historical Comparison
CSBR
ICG

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

Share on Social Networks: